1
|
Rough S, Shane R, Armitstead JA, Belford SM, Brummond PW, Chen D, Collins CM, Dalton H, Dopp AL, Estevez MM, Hager DR, Halbach B, Hays R, Knoer S, Kotis D, Montgomery D, Plummer B, Riester MR, Schreier DJ, Simonson D, Siska MH, Waier K, Vermeulen LC. The high-value pharmacy enterprise framework: Advancing pharmacy practice in health systems through a consensus-based, strategic approach. Am J Health Syst Pharm 2021; 78:498-510. [DOI: 10.1093/ajhp/zxaa431] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
AbstractPurposeThe high-value pharmacy enterprise (HVPE) framework and constituent best practice consensus statements are presented, and the methods used to develop the framework’s 8 domains are described.SummaryA panel of pharmacy leaders used an evidence- and expert opinion–based approach to define core and aspirational elements of practice that should be established within contemporary health-system pharmacy enterprises by calendar year 2025. Eight domains of an HVPE were identified: Patient Care Services; Business Services; Ambulatory and Specialty Pharmacy Services; Inpatient Operations; Safety and Quality; Pharmacy Workforce; Information Technology, Data, and Information Management; and Leadership. Phase 1 of the project consisted of the development of draft practice statements, performance elements, and supporting evidence for each domain by panelists, followed by a phase 2 in-person meeting for review and development of consensus for statements and performance elements in each domain. During phase 3, the project cochairs and panelists finalized the domain drafts and incorporated them into a full technical report and this summary report.ConclusionThe HVPE framework is a strategic roadmap to advance pharmacy practice by ensuring safe, effective, and patient-centered medication management and business practices throughout the health-system pharmacy enterprise. Grounded in evidence and expert recommendations, the statements and associated performance elements can be used to identify strategic priorities to improve patient outcomes and add value within health systems.
Collapse
Affiliation(s)
| | - Rita Shane
- Cedars-Sinai Medical Center, Los Angeles, CA, and UCSF School of Pharmacy, San Francisco, CA
| | | | | | | | - David Chen
- American Society of Health-System Pharmacists, Bethesda, MD
| | | | | | | | | | | | | | - Ryan Hays
- Cedars-Sinai Medical Center, Los Angeles, CA
| | - Scott Knoer
- American Pharmacists Association, Washington, DC
| | - Desi Kotis
- University of California San Francisco, San Francisco, CA, and UCSF Health, San Francisco, CA
| | | | | | | | | | | | | | - Kelsey Waier
- University of California San Francisco, San Francisco, CA, and UCSF Health, San Francisco, CA
| | - Lee C Vermeulen
- University of Kentucky, Lexington, KY, and UK HealthCare, Lexington, KY
| |
Collapse
|